Cameron’s Law
- Introduced Mar 3
- Committee Mar 3
- Passed House Next
- Passed Senate Not yet
- To President Not yet
- Law Not yet
Where it stands
In committee, Mar 3, 2023Next: House vote
1328d ago Mar 10, 2023: Referred to the Subcommittee on Health.
Final votes
No roll callsNo recorded vote on this bill yet
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe
Companies lobbying on this bill
3 companiesCompanies by sector
Biotech & Pharma 3
Search all 3 companies, their asks and price moves Subscribe
Votes
No recorded roll-call vote on this bill yet
Member trades
No member of Congress traded these companies in the last 90 days
Summary
Cameron's Law
Full summary2 paragraphs
This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).
The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.
Library of Congress summary, Mar 3, 2023
Summary versions
- Introduced in HouseMar 3, 2023
Actions
- HouseReferred to the Subcommittee on Health.Mar 10, 2023
- HouseIntroduced in HouseMar 3, 2023
- HouseReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Mar 3, 2023
Bill record
Text versions1
- Introduced in HouseMar 3, 2023PDF: Introduced in House
Committees2
- House Energy and Commerce CommitteeReferred To Mar 3, 2023
- Subcommittee: Health SubcommitteeReferred to
- House Ways and Means CommitteeReferred To Mar 3, 2023
Sponsor and cosponsors1 cosponsor
- Rep. Josh Gottheimer (D-NJ-5)Sponsor, Mar 3, 2023
- Don Bacon (R-NE-2)OriginalJoined Mar 3, 2023
Amendments0
No amendments offered
Cost estimates and reports0
No cost estimate or committee report yet
Titles2
Short titles
- Cameron’s LawShort Title(s) as Introduced
Official titles
- To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit, and for other purposes.Official Title as Introduced
Subjects1
Policy area
Related bills1
- H.R. 2623 117th, Reintroduction of Cameron’s Law
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.